FRIDAY, Sept. 6, 2024 -- Immunotherapy (IO) utilization is increasing over time, but significant socioeconomic disparities exist for patients with...
Vous n'êtes pas connecté
Discover how belzutifan is redefining the treatment of advanced renal cell carcinoma, the most common type of kidney cancer, with its promising results.
FRIDAY, Sept. 6, 2024 -- Immunotherapy (IO) utilization is increasing over time, but significant socioeconomic disparities exist for patients with...
Exosome-based therapy targets squamous cell carcinomas that are drug-resistant and offers new hope for patients with drug-resistant cancers
Exosome-based therapy targets squamous cell carcinomas that are drug-resistant and offers new hope for patients with drug-resistant cancers
People in the Philippines can now receive leading-edge, clinical care recommendations from City of Hope cancer specialists LOS ANGELES — Oncology...
Pancreatic ductal adenocarcinoma is the most common type of pancreatic cancer, with a low five-year survival rate of 13%. It is the third largest...
Atrial fibrillation, a rapid, irregular heart beat that can lead to stroke or sudden death, is three times more common than previously thought,...
Researchers at the National Institute of Biology are exploring new avenues for more effective treatment of glioblastoma, the most aggressive form of...
Mayo Clinic researchers mined the molecular foundations of cancer and uncovered a new reason chimeric antigen receptor (CAR-T cell therapy) fails in...
Researchers at the UCLA Health Jonsson Comprehensive Cancer Center have discovered that Manuka honey could be a promising natural option for...
Discover how Manuka honey's unique properties may slow breast cancer growth and enhance traditional treatments, offering new hope for patients.